MEDTRONIC $MDT JUST REPORTED Q1 EARNINGS
* Revenue: $9.76B (+13.7% YoY), beating est. of $9.54B ๐ข
* Adj EPS: $1.45 (+15.1% YoY), beating est. of $1.39 ๐ข
* Cardiovascular Revenue: $3.9B (+19.5% YoY)
* Diabetes Revenue: $843M (+16.9% YoY)
* Cardiac Ablation Solutions: +88% YoY
* Free Cash Flow: $1.3B
Raises FY27 Guidance:
* Adj EPS: $5.94-$6.00, vs est. of $5.95
* Organic Revenue Growth: 7.25%-7.75%, up from 6.75%-7.25%
Key Updates:
* Announced ~$700M Cornerstone Robotics deal, securing rights to distribute the Sentire surgical robot in select markets outside the U.S.
* Hugo robotic procedures expected to exceed 50,000 globally by fiscal year-end
* Q1 included an extra fiscal week, which added ~$570M to organic revenue growth